DDInter1491 DDInter1625
Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013.
Rubella virus vaccine is a live attenuated virus vaccine for active immunization against rubella (German measles) that is subcutaneously administered. It is prepared from RA 27/3 strain of live attenuated rubella virus. Rubella is a common childhood disease, caused by rubella virus (togavirus).
Pomalidomide {u} (Compound) resembles {v} (Compound) Lenalidomide
Pomalidomide {u} (Compound) binds {v} (Gene) TNF
Pomalidomide {u} (Compound) causes {v} (Side Effect) Dermatitis
Pomalidomide (Compound) resembles Lenalidomide (Compound)
Pomalidomide (Compound) binds TNF (Gene)
Pomalidomide (Compound) causes Dermatitis (Side Effect)